Could live attenuated vaccines better control COVID-19?

In an effort to control the COVID-19 pandemic, large-scale vaccination is being implemented in various countries using anti-SARS-CoV-2 vaccines based on mRNAs, adenovirus vectors, and inactivated viruses. However, there are concerns regarding adverse effects, such as the induction of fever attribute...

Descripción completa

Detalles Bibliográficos
Autores principales: Okamura, Shinya, Ebina, Hirotaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354792/
https://www.ncbi.nlm.nih.gov/pubmed/34426024
http://dx.doi.org/10.1016/j.vaccine.2021.08.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354792/
https://www.ncbi.nlm.nih.gov/pubmed/34426024
http://dx.doi.org/10.1016/j.vaccine.2021.08.018

Ejemplares similares